Cardinal Health, Inc. (CAH) Stock Price and Analyst Predictions

Cardinal Health, Inc. (NYSE: CAH) has a price-to-earnings ratio that is above its average at 43.80x. The stock has a 36-month beta value of 0.70. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 15 as “hold,” and 0 as “sell.”

The public float for CAH is 241.78M, and at present, short sellers hold a 3.56% of that float. On April 03, 2024, the average trading volume of CAH was 2.40M shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

CAH) stock’s latest price update

Cardinal Health, Inc. (NYSE: CAH)’s stock price has plunge by -0.72relation to previous closing price of 112.06. Nevertheless, the company has seen a 0.22% surge in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-03-27 that We believe that stocks like General Motors (GM), Cardinal Health (CAH), Cencora (COR), Alta Equipment (ALTG) and Asbury (ABG) should be on an investor’s watchlist.

CAH’s Market Performance

Cardinal Health, Inc. (CAH) has experienced a 0.22% rise in stock performance for the past week, with a -1.87% drop in the past month, and a 10.37% rise in the past quarter. The volatility ratio for the week is 1.42%, and the volatility levels for the past 30 days are at 2.04% for CAH. The simple moving average for the past 20 days is -0.90% for CAH’s stock, with a 12.70% simple moving average for the past 200 days.

Analysts’ Opinion of CAH

Many brokerage firms have already submitted their reports for CAH stocks, with Leerink Partners repeating the rating for CAH by listing it as a “Outperform.” The predicted price for CAH in the upcoming period, according to Leerink Partners is $125 based on the research report published on February 26, 2024 of the current year 2024.

Barclays gave a rating of “Overweight” to CAH, setting the target price at $117 in the report published on January 03rd of the current year.

CAH Trading at 2.39% from the 50-Day Moving Average

After a stumble in the market that brought CAH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.13% of loss for the given period.

Volatility was left at 2.04%, however, over the last 30 days, the volatility rate increased by 1.42%, as shares sank -1.23% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.47% upper at present.

During the last 5 trading sessions, CAH rose by +0.22%, which changed the moving average for the period of 200-days by +27.92% in comparison to the 20-day moving average, which settled at $112.19. In addition, Cardinal Health, Inc. saw 10.37% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CAH starting from WEITZMAN DEBORAH, who sale 36,642 shares at the price of $106.31 back on Nov 27 ’23. After this action, WEITZMAN DEBORAH now owns 35,202 shares of Cardinal Health, Inc., valued at $3,895,411 using the latest closing price.

WEITZMAN DEBORAH, the CEO, Pharmaceutical Segment of Cardinal Health, Inc., sale 6,712 shares at $89.81 during a trade that took place back on Aug 28 ’23, which means that WEITZMAN DEBORAH is holding 44,202 shares at $602,805 based on the most recent closing price.

Stock Fundamentals for CAH

Current profitability levels for the company are sitting at:

  • 0.01 for the present operating margin
  • 0.03 for the gross margin

The net margin for Cardinal Health, Inc. stands at 0.0. The total capital return value is set at 0.14.

Based on Cardinal Health, Inc. (CAH), the company’s capital structure generated 3.71 points at debt to capital in total, while cash flow to debt ratio is standing at 0.84. The debt to equity ratio resting at -1.37. The interest coverage ratio of the stock is 18.11.

Currently, EBITDA for the company is 2.47 billion with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 0.13. The receivables turnover for the company is 18.34for trailing twelve months and the total asset turnover is 4.64. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.98.


To sum up, Cardinal Health, Inc. (CAH) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts